535 related articles for article (PubMed ID: 12318226)
21. [Veins and contraception].
Reinharez D; Monsonego J
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
[TBL] [Abstract][Full Text] [Related]
22. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
23. Developments in new progestagens for oral contraception.
Eyong E
IPPF Med Bull; 1987 Apr; 21(2):3-4. PubMed ID: 12268598
[TBL] [Abstract][Full Text] [Related]
24. [Contraception for the diabetic woman].
Arlot S; Mesmacque A; Lalau JD; Quichaud J
Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
[TBL] [Abstract][Full Text] [Related]
25. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
Lidegaard O
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
[TBL] [Abstract][Full Text] [Related]
26. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
27. [Metrorrhagia caused by estrogen-progestin combinations].
Erny R; Erny N
Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
[TBL] [Abstract][Full Text] [Related]
28. [Current issues in contraception].
Audebert AJ
Contracept Fertil Sex (Paris); 1985 Feb; 13(2):467-73. PubMed ID: 12339971
[TBL] [Abstract][Full Text] [Related]
29. [Macroprogestative contraception: advantages].
Jamin C
Contracept Fertil Sex (Paris); 1993 Feb; 21(2):123-8. PubMed ID: 12318009
[TBL] [Abstract][Full Text] [Related]
30. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
31. Coagulation profile in women on low-dose oral contraceptive pills.
Roshidah I; Khalid H; Baharum Y
Malays J Reprod Health; 1990 Dec; 8(2):97-100. PubMed ID: 12343152
[TBL] [Abstract][Full Text] [Related]
32. Desogestrel, norgestimate, and gestodene: the newer progestins.
Kaplan B
Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
[TBL] [Abstract][Full Text] [Related]
33. Triphasics: have they fulfilled their promise?
Weisberg E
Curr Ther (Seaforth); 1992 Jan; 33(1):11-6. PubMed ID: 12286973
[TBL] [Abstract][Full Text] [Related]
34. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
35. [Oral contraception, glucid metabolism and monitoring criteria].
Gaspard U
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of biphasic and triphasic pills.
Cohen J
IPPF Med Bull; 1985 Aug; 19(4):1-2. PubMed ID: 12280230
[TBL] [Abstract][Full Text] [Related]
37. Update on the metabolic effects of steroidal contraceptives.
Sondheimer SJ
Endocrinol Metab Clin North Am; 1991 Dec; 20(4):911-23. PubMed ID: 1778182
[TBL] [Abstract][Full Text] [Related]
38. The new pills: awaiting the next generation of oral contraceptives.
Klitsch M
Fam Plann Perspect; 1992; 24(5):226-8. PubMed ID: 1426186
[TBL] [Abstract][Full Text] [Related]
39. [Oral contraceptives and blood platelets].
Davenas E; Ciavatti M; Poitevin B; Aubin M
Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
[TBL] [Abstract][Full Text] [Related]
40. [Preclinical research and development of norethisterone].
Mcguire JL; Hahn DW; Philipps A
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
